# A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation

> **NCT03714178** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 71 (actual)

## Conditions studied

- Paroxysmal Atrial Fibrillation

## Interventions

- **DEVICE:** FARAPULSE Endocardial Ablation System

## Key facts

- **NCT ID:** NCT03714178
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-20
- **Primary completion:** 2020-12-21
- **Final completion:** 2020-12-21
- **Target enrollment:** 71 (ACTUAL)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03714178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03714178, "A Safety and Feasibility Study of the FARAPULSE Endocardial Ablation System to Treat Paroxysmal Atrial Fibrillation". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT03714178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*